secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLEARONE INC (CLRO)
CIK:        0000840715
Form:       8-K
Filed at:   2026-07-06T20:30:22+00:00
Accession:  0001753926-26-001137
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearOne to acquire Cortigent from Vivani Medical in stock deal; plans $10-15M financing
--------------------------------------------------------------------------------

- ClearOne (CLRO) will issue 12.5M shares to Vivani (VANI) for Cortigent, a neurostimulation firm.
- Concurrent S-1 registration to raise $10M-$15M via units of common stock and warrants.
- Post-closing board set at 5 members: Adam Mendelsohn (Chair), Jonathan Adams, John Bowers, Linda Szyper, Eric Robinson.
- Jonathan Adams to be President & CEO; Ed Sedo CFO; Rachel Evans Corporate Secretary.
- Closing conditions include stockholder approvals, financing completion, and Nasdaq continued listing; 180-day termination right.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/840715/000175392626001137/0001753926-26-001137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/840715/000175392626001137/clro-20260706.htm
  HTML page:      https://secwatch.observer/filing/0001753926-26-001137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer